Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 14, 2025 10:00 ET | Source: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sanofi - SNY

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sanofi (“Sanofi” or the “Company”) (NASDAQ: SNY). Such investors are advised to contact...
July 14, 2025 08:00 ET | Source: Recludix Pharma, Inc.

Recludix Pharma Announces Strengthening of Leadership Team, Including Promotion of Dr. Brian Hodous to Chief Scientific Officer

--Brian Hodous, Ph.D., promoted to chief scientific officer -- Vivek Kadambi, Ph.D., joins Recludix as senior vice president of non-clinical sciences and CMC -- Kristin Polsenski, M.B.A., expands...
July 14, 2025 06:04 ET | Source: Research and Markets

Europe Glucagon-like Peptide-1 (GLP-1) Agonists Research Report 2025 | Market to Reach $14.34 Billion by 2034, Driven by Innovative R&D, Strategic Collaborations, and Drug Formulation Advancements

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering. The...
July 14, 2025 03:00 ET | Source: OMass Therapeutics

OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025

PRESS RELEASE OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025 OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH...
July 10, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight ...
July 10, 2025 09:00 ET | Source: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sanofi (“Sanofi” or the “Company”) (NASDAQ: SNY). Such investors are advised to contact...
July 09, 2025 16:01 ET | Source: Nurix Therapeutics, Inc.

Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and...
July 09, 2025 12:29 ET | Source: Sanofi Winthrop Industrie

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juin 2025

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
July 09, 2025 12:29 ET | Source: Sanofi Winthrop Industrie

Sanofi: Information concerning the total number of voting rights and shares - June 2025

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
July 09, 2025 09:20 ET | Source: SNS Insider pvt ltd

Retinal Biologics Market Set to Hit USD 49.5 Billion by 2032, Fueled by Aging Population and Precision Biologic Innovations - SNS Insider

Austin, July 09, 2025 (GLOBE NEWSWIRE) -- Retinal Biologics Market Size & Growth Analysis: According to SNS Insider, the global Retinal Biologics Market was valued at USD 22.50 billion in 2023...